Analyst Coverage
| Firm | Analyst |
|---|---|
|
Berenberg
|
Caroline Palomeque |
|
BofA Securities, Inc.
|
Jason Gerberry |
|
Cantor Fitzgerald
|
Charles C. Duncan, Ph.D. |
|
Goldman Sachs & Co. LLC
|
Salveen Richter, CFA |
|
Guggenheim Securities, LLC
|
Yatin Suneja |
|
H.C. Wainwright
|
Raghuram Selvaraju, Ph.D. |
|
J.P. Morgan Securities LLC
|
Jessica Fye |
|
JMP Securities
|
Jason N. Butler, PhD |
|
Maxim
|
Jason McCarthy, Ph.D. |
|
Mizuho
|
Graig Suvannavejh |
|
Oppenheimer
|
Jay Olson, CFA |
|
Piper Sandler
|
David Amsellem |
|
RBC Capital Markets
|
Brian Abrahams |
|
Stifel
|
Paul Matteis |
|
Leerink Partners
|
Marc Goodman |
|
UBS
|
Ash Verma |
|
Wedbush Securities, Inc.
|
Laura Chico, Ph.D |
|
Wells Fargo Securities, LLC
|
Mohit Bansal |
|
William Blair
|
Myles Minter, Ph.D. |
Karuna Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Karuna Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Karuna Therapeutics or its management. Karuna Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.